Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats

doi:10.4239/wjd.v13.i8.613

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3492)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series.

Item

Count

PDF

138

WORD

HTML

1922

Figures (1-5)

360

Sum=2473

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

352

Download

667

Sum=1019

Aug 15, 2022 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Aug 15, 2022; 13(8): 613-621
Published online Aug 15, 2022. doi: 10.4239/wjd.v13.i8.613

Full Size Figure Download Figure

Figure 4 The effect of glucagon-like peptide-1 nanoparticles on the viability of Michigan Cancer Foundation-7 cells. The carbonate apatite nanoparticles with increasing glucagon-like peptide-1 concentrations did not affect the viability of the cells.

Citation: Ibnat N, Zaman R, Uddin MB, Chowdhury E, Lee CY. Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats. World J Diabetes 2022; 13(8): 613-621
URL: https://www.wjgnet.com/1948-9358/full/v13/i8/613.htm
DOI: https://dx.doi.org/10.4239/wjd.v13.i8.613